Cargando…
Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings
IMPORTANCE: Over half of adults in the United States report consuming dietary supplements. The US Food and Drug Administration (FDA) has warned of numerous dietary supplements containing undeclared, unapproved pharmaceutical ingredients. These FDA warnings have not been comprehensively analyzed for...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324457/ https://www.ncbi.nlm.nih.gov/pubmed/30646238 http://dx.doi.org/10.1001/jamanetworkopen.2018.3337 |
_version_ | 1783385977251692544 |
---|---|
author | Tucker, Jenna Fischer, Tessa Upjohn, Laurence Mazzera, David Kumar, Madhur |
author_facet | Tucker, Jenna Fischer, Tessa Upjohn, Laurence Mazzera, David Kumar, Madhur |
author_sort | Tucker, Jenna |
collection | PubMed |
description | IMPORTANCE: Over half of adults in the United States report consuming dietary supplements. The US Food and Drug Administration (FDA) has warned of numerous dietary supplements containing undeclared, unapproved pharmaceutical ingredients. These FDA warnings have not been comprehensively analyzed for recent years. OBJECTIVE: To summarize trends across adulterated (containing unapproved ingredients) dietary supplements associated with a warning released by the FDA from 2007 through 2016. DESIGN, SETTING, AND PARTICIPANTS: In this quality improvement study, data were extracted from the FDA’s Center for Drug Evaluation and Research, Tainted Products Marketed as Dietary Supplements_CDER database from 2007 through 2016. Data from each warning were recorded unless multiple warnings were issued for the same product within a 6-month period. Date, product name, company, hidden ingredient(s), product category, source of sample, and warning document type were recorded for each included warning. Data analysis was conducted from February 2017 to June 2017. RESULTS: From 2007 through 2016, 776 adulterated dietary supplements were identified by the FDA and 146 different dietary supplement companies were implicated. Most of these products were marketed for sexual enhancement (353 [45.5%]), weight loss (317 [40.9%]), or muscle building (92 [11.9%]), with 157 adulterated products (20.2%) containing more than 1 unapproved ingredient. The most common adulterants were sildenafil for sexual enhancement supplements (166 of 353 [47.0%]), sibutramine for weight loss supplements (269 of 317 [84.9%]), and synthetic steroids or steroid-like ingredients for muscle building supplements (82 of 92 [89.1%]). There were 28 products named in 2 or 3 warnings more than 6 months apart. Of these products, 19 (67.9%) were reported to contain new unapproved ingredients in the second or third warning, consistent with the assumption that the FDA found the product to be adulterated more than once. In recent years (2014-2016), 117 of 303 adulterated samples (38.6%) were identified through online sampling and 104 of 303 (34.3%) were identified through the examination of international mail shipments. CONCLUSIONS AND RELEVANCE: Active pharmaceuticals continue to be identified in dietary supplements, especially those marketed for sexual enhancement or weight loss, even after FDA warnings. The drug ingredients in these dietary supplements have the potential to cause serious adverse health effects owing to accidental misuse, overuse, or interaction with other medications, underlying health conditions, or other pharmaceuticals within the supplement. |
format | Online Article Text |
id | pubmed-6324457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-63244572019-01-22 Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings Tucker, Jenna Fischer, Tessa Upjohn, Laurence Mazzera, David Kumar, Madhur JAMA Netw Open Original Investigation IMPORTANCE: Over half of adults in the United States report consuming dietary supplements. The US Food and Drug Administration (FDA) has warned of numerous dietary supplements containing undeclared, unapproved pharmaceutical ingredients. These FDA warnings have not been comprehensively analyzed for recent years. OBJECTIVE: To summarize trends across adulterated (containing unapproved ingredients) dietary supplements associated with a warning released by the FDA from 2007 through 2016. DESIGN, SETTING, AND PARTICIPANTS: In this quality improvement study, data were extracted from the FDA’s Center for Drug Evaluation and Research, Tainted Products Marketed as Dietary Supplements_CDER database from 2007 through 2016. Data from each warning were recorded unless multiple warnings were issued for the same product within a 6-month period. Date, product name, company, hidden ingredient(s), product category, source of sample, and warning document type were recorded for each included warning. Data analysis was conducted from February 2017 to June 2017. RESULTS: From 2007 through 2016, 776 adulterated dietary supplements were identified by the FDA and 146 different dietary supplement companies were implicated. Most of these products were marketed for sexual enhancement (353 [45.5%]), weight loss (317 [40.9%]), or muscle building (92 [11.9%]), with 157 adulterated products (20.2%) containing more than 1 unapproved ingredient. The most common adulterants were sildenafil for sexual enhancement supplements (166 of 353 [47.0%]), sibutramine for weight loss supplements (269 of 317 [84.9%]), and synthetic steroids or steroid-like ingredients for muscle building supplements (82 of 92 [89.1%]). There were 28 products named in 2 or 3 warnings more than 6 months apart. Of these products, 19 (67.9%) were reported to contain new unapproved ingredients in the second or third warning, consistent with the assumption that the FDA found the product to be adulterated more than once. In recent years (2014-2016), 117 of 303 adulterated samples (38.6%) were identified through online sampling and 104 of 303 (34.3%) were identified through the examination of international mail shipments. CONCLUSIONS AND RELEVANCE: Active pharmaceuticals continue to be identified in dietary supplements, especially those marketed for sexual enhancement or weight loss, even after FDA warnings. The drug ingredients in these dietary supplements have the potential to cause serious adverse health effects owing to accidental misuse, overuse, or interaction with other medications, underlying health conditions, or other pharmaceuticals within the supplement. American Medical Association 2018-10-12 /pmc/articles/PMC6324457/ /pubmed/30646238 http://dx.doi.org/10.1001/jamanetworkopen.2018.3337 Text en Copyright 2018 Tucker J et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Tucker, Jenna Fischer, Tessa Upjohn, Laurence Mazzera, David Kumar, Madhur Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings |
title | Unapproved Pharmaceutical Ingredients Included in Dietary Supplements
Associated With US Food and Drug Administration Warnings |
title_full | Unapproved Pharmaceutical Ingredients Included in Dietary Supplements
Associated With US Food and Drug Administration Warnings |
title_fullStr | Unapproved Pharmaceutical Ingredients Included in Dietary Supplements
Associated With US Food and Drug Administration Warnings |
title_full_unstemmed | Unapproved Pharmaceutical Ingredients Included in Dietary Supplements
Associated With US Food and Drug Administration Warnings |
title_short | Unapproved Pharmaceutical Ingredients Included in Dietary Supplements
Associated With US Food and Drug Administration Warnings |
title_sort | unapproved pharmaceutical ingredients included in dietary supplements
associated with us food and drug administration warnings |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324457/ https://www.ncbi.nlm.nih.gov/pubmed/30646238 http://dx.doi.org/10.1001/jamanetworkopen.2018.3337 |
work_keys_str_mv | AT tuckerjenna unapprovedpharmaceuticalingredientsincludedindietarysupplementsassociatedwithusfoodanddrugadministrationwarnings AT fischertessa unapprovedpharmaceuticalingredientsincludedindietarysupplementsassociatedwithusfoodanddrugadministrationwarnings AT upjohnlaurence unapprovedpharmaceuticalingredientsincludedindietarysupplementsassociatedwithusfoodanddrugadministrationwarnings AT mazzeradavid unapprovedpharmaceuticalingredientsincludedindietarysupplementsassociatedwithusfoodanddrugadministrationwarnings AT kumarmadhur unapprovedpharmaceuticalingredientsincludedindietarysupplementsassociatedwithusfoodanddrugadministrationwarnings |